APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT07434635
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Eye Disorders

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Atropine 1% — DRUG
    Subtraction of atropine eyedrops from post-operative treatment regimen

Study Details

The study will evaluate whether atropine eyedrops are beneficial when used after certain eye surgeries.

Key Dates

Start date
Feb 28, 2026
Status verified
Feb 2026
Primary completion
Feb 29, 2028
Completion
Feb 28, 2029

Study Design

Enrollment
62 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • No Intervention: Control
    No atropine
  • Experimental: Experimental
    Participant uses atropine eyedrops

Primary Outcome Measure

Pain score on the Visual Analog Scale (VAS) [ Time Frame: 1 month ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94143
Jay Stewart
[email protected]
415-353-9635

Find similar trials in San Francisco, CA

By research site
University of California, San Francisco· San Francisco, CA

Related Studies